Phase 2 Chronic Low Back Pain Study
A Phase 2, Randomized Withdrawal Study of the Analgesic Efficacy and Safety of Hydrocodone/Acetaminophen Extended Release Compared to Placebo in Subjects With Chronic Low Back Pain
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Fase 2
Kontakter og lokationer
Studiesteder
-
-
Arizona
-
Tucson, Arizona, Forenede Stater, 85704
- Site Reference ID/Investigator# 54875
-
-
California
-
Anaheim, California, Forenede Stater, 92801
- Site Reference ID/Investigator# 54876
-
Burbank, California, Forenede Stater, 91505
- Site Reference ID/Investigator# 54877
-
Lomita, California, Forenede Stater, 90717
- Site Reference ID/Investigator# 54873
-
-
Florida
-
DeLand, Florida, Forenede Stater, 32720
- Site Reference ID/Investigator# 54874
-
Oldsmar, Florida, Forenede Stater, 34677
- Site Reference ID/Investigator# 54866
-
-
Georgia
-
Marietta, Georgia, Forenede Stater, 30060
- Site Reference ID/Investigator# 54879
-
-
Indiana
-
Valparaiso, Indiana, Forenede Stater, 46383
- Site Reference ID/Investigator# 54865
-
-
Kansas
-
Prairie Village, Kansas, Forenede Stater, 66206
- Site Reference ID/Investigator# 54782
-
-
Maryland
-
Pasadena, Maryland, Forenede Stater, 21122
- Site Reference ID/Investigator# 54862
-
-
Massachusetts
-
Watertown, Massachusetts, Forenede Stater, 02472-3930
- Site Reference ID/Investigator# 54878
-
-
Missouri
-
St. Louis, Missouri, Forenede Stater, 63141
- Site Reference ID/Investigator# 54880
-
-
New York
-
Williamsville, New York, Forenede Stater, 14221
- Site Reference ID/Investigator# 54881
-
-
Ohio
-
Cincinnati, Ohio, Forenede Stater, 45227
- Site Reference ID/Investigator# 54872
-
Marion, Ohio, Forenede Stater, 43302
- Site Reference ID/Investigator# 54863
-
-
Texas
-
Killeen, Texas, Forenede Stater, 76543
- Site Reference ID/Investigator# 54745
-
San Antonio, Texas, Forenede Stater, 78209-1744
- Site Reference ID/Investigator# 54742
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
Adult subjects who have a diagnosis of chronic low back pain of at least 6 month duration
Exclusion Criteria:
Subjects with a history of surgical or invasive intervention
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Open-label Hydrocodone/Acetaminophen Extended Release
Hydrocodone/acetaminophen extended release, 2 tablets twice daily
|
Andre navne:
|
|
Eksperimentel: Double-blind Hydrocodone/Acetaminophen Extended Release
Hydrocodone/acetaminophen extended release, 1 tablet twice daily
|
Andre navne:
|
|
Placebo komparator: Double-blind Placebo
Placebo, 1 tablet twice daily
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change From Double-blind Baseline in Chronic Lower Back Pain (CLBP) Intensity by Visual Analog Scale (VAS)
Tidsramme: Double-blind baseline to Day 29
|
The change from the double-blind randomization baseline (DB baseline: the last assessment before first dose in the double-blind period) to the final assessment in pain intensity, assessed using the CLBP Intensity VAS (0 mm = No Pain and 100 mm = Worst Pain Imaginable).
Least squares means and standard errors from an ANCOVA model.
|
Double-blind baseline to Day 29
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Participant's Global Assessment of Back Pain Status at Final Evaluation
Tidsramme: Double-blind baseline to Day 29
|
The participant's overall impression of their back pain status was obtained by having the participant answer the question "Considering all the ways your chronic low back pain affects you, how are you doing today?" on a 5-point categorical scale: very good (no symptoms and no limitation of normal activities); good (mild symptoms and no limitation of normal activities); fair (moderate symptoms and limitation of some normal activities); poor (severe symptoms and inability to carry out most normal activities); very poor (very severe symptoms which are intolerable and inability to carry out all normal activities).
|
Double-blind baseline to Day 29
|
|
Participant's Global Assessment of Study Drug at Final Evaluation
Tidsramme: Double-blind baseline to Day 29
|
The participant's overall impression of the study drug was obtained by having the participant answer the question "How would you rate your overall response to the study medication?" on a 5-point categorical scale: excellent; very good; good; fair; poor.
|
Double-blind baseline to Day 29
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Smerte
- Neurologiske manifestationer
- Rygsmerte
- Lændesmerter
- Lægemidlers fysiologiske virkninger
- Depressive midler til centralnervesystemet
- Agenter fra det perifere nervesystem
- Analgetika
- Sensoriske systemagenter
- Anti-inflammatoriske midler, ikke-steroide
- Analgetika, ikke-narkotisk
- Anti-inflammatoriske midler
- Antirheumatiske midler
- Antipyretika
- Analgetika, Opioid
- Narkotika
- Respiratoriske midler
- Hostestillende midler
- Acetaminophen
- Hydrocodon
- Acetaminophen, hydrocodon-lægemiddelkombination
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- M12-807
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .